missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Pyrroles
  7. Ulixertinib, MedChemExpress

Ulixertinib, MedChemExpress

Product Code. 16499387
Encompass_Preferred
Change view
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
200 mg
Unit Size:
100mg
10mg
200mg
50mg
5mg
5 product options available for selection
Product selection table with 5 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16499387 5 mg 5mg
16496946 100 mg 100mg
16456848 10 mg 10mg
16452917 50 mg 50mg
16421206 200 mg 200mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 5 options available.
5 options
This item is not returnable. View return policy
Product Code. 16499387 Supplier Medchem Express Supplier No. HY15816
 Restricted Item
Estimated Shipment: 13-08-2026
Add to basket
Add to basket
This item is not returnable. View return policy

Description

MedChemExpress Ulixertinib (BVD-523; VRT752271) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of <0.3 nM against ERK2. Ulixertinib (BVD-523; VRT752271) inhibits the phosphorylated ERK2 (pERK) and downstream kinase RSK (pRSK) in an A375 melanoma cell line.

Ulixertinib (BVD-523

Specifications

Chemical Name or Material Ulixertinib
CAS 869886-67-9
Color White
Purity Grade Notes Research
Molecular Formula C21H22Cl2N4O2
Quantity 5 mg
Synonym BVD-523 VRT752271
Solubility Information DMSO : 100 mg/mL (230.77 mM; Need ultrasonic)
SMILES O=C(C1=CC(C2=CC(NC(C)C)=NC=C2Cl)=CN1)N[C@@H](C3=CC=CC(Cl)=C3)CO
Molecular Weight (g/mol) 433.33
Formula Weight 433.33
Percent Purity 98.44%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.